tiprankstipranks
Trending News
More News >
Xvivo Perfusion AB (GB:0RKL)
LSE:0RKL

Xvivo Perfusion AB (0RKL) Revenue

Compare
0 Followers

Xvivo Perfusion AB Revenue

Xvivo Perfusion AB had a revenue of 218.59M in the quarter ending Mar 31, 2025, with -3.94%. This bring the company's revenue in the last twelve months to 854.98M, Decreased 3.96%. In the fiscal year ending Dec 31, 2024, Xvivo Perfusion AB had annual revenue of 822.41M with 37.63% growth.
Revenue (ttm)
854.98M
Revenue Growth
P/S Ratio
11.61
Revenue/Employee
$4,261,218
Employees
193
Market Cap
$9.54B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
822.41M224.87M+37.63%
Dec 31, 2023
597.54M182.25M+43.88%
Dec 31, 2022
415.29M156.91M+60.73%
Dec 31, 2021
258.39M78.53M+43.66%
Dec 31, 2020
179.86M-40.98M-18.56%
Dec 31, 2019
220.84M32.97M+17.55%
Dec 31, 2018
187.87M39.53M+26.65%
Dec 31, 2017
148.34M10.16M+7.36%
Dec 31, 2016
138.18M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis